Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lemaître N[au]:

Search results

Items: 49

1.

Prospective evaluation of the Amplidiag® CarbaR+VRE assay for direct screening of carbapenemase producing gram-negative bacilli from rectal swabs.

Nadji S, Gaillot O, Hallaert C, Messaadi S, Loukili N, Naas T, Lemaître N.

Diagn Microbiol Infect Dis. 2019 Dec;95(4):114890. doi: 10.1016/j.diagmicrobio.2019.114890. Epub 2019 Aug 24.

PMID:
31630910
2.

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.

Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, Sertier AS, Ferrari A, Derks J, Ghantous A, Delhomme TM, Chabrier A, Cuenin C, Abedi-Ardekani B, Boland A, Olaso R, Meyer V, Altmuller J, Le Calvez-Kelm F, Durand G, Voegele C, Boyault S, Moonen L, Lemaitre N, Lorimier P, Toffart AC, Soltermann A, Clement JH, Saenger J, Field JK, Brevet M, Blanc-Fournier C, Galateau-Salle F, Le Stang N, Russell PA, Wright G, Sozzi G, Pastorino U, Lacomme S, Vignaud JM, Hofman V, Hofman P, Brustugun OT, Lund-Iversen M, Thomas de Montpreville V, Muscarella LA, Graziano P, Popper H, Stojsic J, Deleuze JF, Herceg Z, Viari A, Nuernberg P, Pelosi G, Dingemans AMC, Milione M, Roz L, Brcic L, Volante M, Papotti MG, Caux C, Sandoval J, Hernandez-Vargas H, Brambilla E, Speel EJM, Girard N, Lantuejoul S, McKay JD, Foll M, Fernandez-Cuesta L.

Nat Commun. 2019 Aug 20;10(1):3407. doi: 10.1038/s41467-019-11276-9.

3.

Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus Lactis in a Pseudotuberculosis Mouse Model.

Daniel C, Dewitte A, Poiret S, Marceau M, Simonet M, Marceau L, Descombes G, Boutillier D, Bennaceur N, Bontemps-Gallo S, Lemaître N, Sebbane F.

Front Immunol. 2019 Aug 2;10:1830. doi: 10.3389/fimmu.2019.01830. eCollection 2019.

4.

VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop.

Boudria A, Abou Faycal C, Jia T, Gout S, Keramidas M, Didier C, Lemaître N, Manet S, Coll JL, Toffart AC, Moro-Sibilot D, Albiges-Rizo C, Josserand V, Faurobert E, Brambilla C, Brambilla E, Gazzeri S, Eymin B.

Oncogene. 2019 Feb;38(7):1050-1066. doi: 10.1038/s41388-018-0486-7. Epub 2018 Sep 7.

5.

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.

Abou Faycal C, Brambilla E, Agorreta J, Lepeltier N, Jacquet T, Lemaître N, Emadali A, Lucas A, Lacal PM, Montuenga L, Pio R, Gazzeri S, Eymin B.

Br J Cancer. 2018 Jun;118(12):1596-1608. doi: 10.1038/s41416-018-0128-4. Epub 2018 May 24.

6.

Plague: Bridging gaps towards better disease control.

D'Ortenzio E, Lemaître N, Brouat C, Loubet P, Sebbane F, Rajerison M, Baril L, Yazdanpanah Y.

Med Mal Infect. 2018 Aug;48(5):307-317. doi: 10.1016/j.medmal.2018.04.393. Epub 2018 Jun 1. Review.

PMID:
29773334
7.

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.

George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, Maas L, Müller C, Dahmen I, Delhomme TM, Ardin M, Leblay N, Byrnes G, Sun R, De Reynies A, McLeer-Florin A, Bosco G, Malchers F, Menon R, Altmüller J, Becker C, Nürnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soloway MG, Wilkerson MD, Cun Y, McKay JD, Moro-Sibilot D, Brambilla CG, Lantuejoul S, Lemaitre N, Soltermann A, Weder W, Tischler V, Brustugun OT, Lund-Iversen M, Helland Å, Solberg S, Ansén S, Wright G, Solomon B, Roz L, Pastorino U, Petersen I, Clement JH, Sänger J, Wolf J, Vingron M, Zander T, Perner S, Travis WD, Haas SA, Olivier M, Foll M, Büttner R, Hayes DN, Brambilla E, Fernandez-Cuesta L, Thomas RK.

Nat Commun. 2018 Mar 13;9(1):1048. doi: 10.1038/s41467-018-03099-x.

8.

Is a chlorine dioxide wiping procedure suitable for the high-level disinfection of nasendoscopes?

Henoun Loukili N, Lemaitre N, Guery B, Gaillot O, Chevalier D, Mortuaire G.

J Infect Prev. 2017 Mar;18(2):78-83. doi: 10.1177/1757177416679879. Epub 2016 Dec 18.

9.

Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.

Lemaître N, Liang X, Najeeb J, Lee CJ, Titecat M, Leteurtre E, Simonet M, Toone EJ, Zhou P, Sebbane F.

MBio. 2017 Jul 25;8(4). pii: e00674-17. doi: 10.1128/mBio.00674-17.

10.

TiO2 Anatase Solutions for Electron Transporting Layers in Organic Photovoltaic Cells.

El Kass M, Brohan L, Gautier N, Béchu S, David C, Lemaitre N, Berson S, Richard-Plouet M.

Chemphyschem. 2017 Sep 6;18(17):2390-2396. doi: 10.1002/cphc.201700306. Epub 2017 Jul 26.

PMID:
28605155
11.

Diagnostic accuracy of the Xpert® MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.

Lange B, Khan P, Kalmambetova G, Al-Darraji HA, Alland D, Antonenka U, Brown T, Balcells ME, Blakemore R, Denkinger CM, Dheda K, Hoffmann H, Kadyrov A, Lemaitre N, Miller MB, Nikolayevskyy V, Ntinginya EN, Ozkutuk N, Palacios JJ, Popowitch EB, Porcel JM, Teo J, Theron G, Kranzer K.

Int J Tuberc Lung Dis. 2017 May 1;21(5):493-502. doi: 10.5588/ijtld.16.0702. Review.

PMID:
28399963
12.

Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.

Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A; CNR MyRMA and the Tuberculosis Consilium of the CNR MyRMA; CNR MyRMA and Tuberculosis Consilium of the CNR MyRMA.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601719. doi: 10.1183/13993003.01719-2016. Print 2017 Mar. No abstract available.

13.

Emergence and dissemination of a linezolid-resistant Staphylococcus capitis clone in Europe.

Butin M, Martins-Simões P, Pichon B, Leyssene D, Bordes-Couecou S, Meugnier H, Rouard C, Lemaitre N, Schramm F, Kearns A, Spiliopoulou I, Hyyryläinen HL, Dumitrescu O, Vandenesch F, Dupieux C, Laurent F.

J Antimicrob Chemother. 2017 Apr 1;72(4):1014-1020. doi: 10.1093/jac/dkw516.

PMID:
27999045
14.

Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.

Daniel C, Titecat M, Poiret S, Cayet D, Boutillier D, Simonet M, Sirard JC, Lemaître N, Sebbane F.

Vaccine. 2016 Nov 11;34(47):5762-5767. doi: 10.1016/j.vaccine.2016.09.060. Epub 2016 Oct 11.

PMID:
27742220
15.

High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.

Titecat M, Liang X, Lee CJ, Charlet A, Hocquet D, Lambert T, Pagès JM, Courcol R, Sebbane F, Toone EJ, Zhou P, Lemaitre N.

J Antimicrob Chemother. 2016 Oct;71(10):2874-82. doi: 10.1093/jac/dkw210. Epub 2016 Jun 20.

16.

Drug design from the cryptic inhibitor envelope.

Lee CJ, Liang X, Wu Q, Najeeb J, Zhao J, Gopalaswamy R, Titecat M, Sebbane F, Lemaitre N, Toone EJ, Zhou P.

Nat Commun. 2016 Feb 25;7:10638. doi: 10.1038/ncomms10638.

17.

Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study.

Pankhurst LJ, Del Ojo Elias C, Votintseva AA, Walker TM, Cole K, Davies J, Fermont JM, Gascoyne-Binzi DM, Kohl TA, Kong C, Lemaitre N, Niemann S, Paul J, Rogers TR, Roycroft E, Smith EG, Supply P, Tang P, Wilcox MH, Wordsworth S, Wyllie D, Xu L, Crook DW; COMPASS-TB Study Group.

Lancet Respir Med. 2016 Jan;4(1):49-58. doi: 10.1016/S2213-2600(15)00466-X. Epub 2015 Dec 4.

18.

Disseminated Infection Caused by Francisella philomiragia, France, 2014.

Kreitmann L, Terriou L, Launay D, Caspar Y, Courcol R, Maurin M, Lemaître N.

Emerg Infect Dis. 2015 Dec;21(12):2260-1. doi: 10.3201/eid2112.150615. No abstract available.

19.

Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient.

Renvoisé A, Lemaitre N, Saintenoy G, Benosman H, Geffrier C, Epelboin L, Jarlier V, Poynard T, Thabut D.

Int J Infect Dis. 2015 May;34:122-5. doi: 10.1016/j.ijid.2015.03.019. Epub 2015 Mar 30.

20.

Yersinia pestis requires the 2-component regulatory system OmpR-EnvZ to resist innate immunity during the early and late stages of plague.

Reboul A, Lemaître N, Titecat M, Merchez M, Deloison G, Ricard I, Pradel E, Marceau M, Sebbane F.

J Infect Dis. 2014 Nov 1;210(9):1367-75. doi: 10.1093/infdis/jiu274. Epub 2014 May 9.

PMID:
24813471
21.

First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.

Aubry A, Sougakoff W, Bodzongo P, Delcroix G, Armand S, Millot G, Jarlier V, Courcol R, Lemaître N.

PLoS One. 2014 Apr 17;9(4):e95083. doi: 10.1371/journal.pone.0095083. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113219.

22.

New insights into how Yersinia pestis adapts to its mammalian host during bubonic plague.

Pradel E, Lemaître N, Merchez M, Ricard I, Reboul A, Dewitte A, Sebbane F.

PLoS Pathog. 2014 Mar 27;10(3):e1004029. doi: 10.1371/journal.ppat.1004029. eCollection 2014 Mar.

23.

Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response.

Derbise A, Pierre F, Merchez M, Pradel E, Laouami S, Ricard I, Sirard JC, Fritz J, Lemaître N, Akinbi H, Boneca IG, Sebbane F.

J Infect Dis. 2013 May 15;207(10):1535-43. doi: 10.1093/infdis/jit057. Epub 2013 Feb 12.

PMID:
23402825
24.

Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.

Lemaître N, Ricard I, Pradel E, Foligné B, Courcol R, Simonet M, Sebbane F.

PLoS One. 2012;7(12):e52503. doi: 10.1371/journal.pone.0052503. Epub 2012 Dec 20.

25.

First case of cerebral abscess due to a novel Nocardia species in an immunocompromised patient.

Flateau C, Jurado V, Lemaître N, Loïez C, Wallet F, Saiz-Jimenez C, Decoene C, Bergeron E, Boiron P, Faure K, Guery B, Rodríguez-Nava V.

J Clin Microbiol. 2013 Feb;51(2):696-700. doi: 10.1128/JCM.00762-12. Epub 2012 Dec 5.

26.

Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study.

Vuotto F, Berthon C, Lemaitre N, Duhamel A, Balkaran S, Le Ray E, Micol JB, Faure K, Alfandari S.

Am J Infect Control. 2013 Jun;41(6):527-30. doi: 10.1016/j.ajic.2012.07.012. Epub 2012 Dec 7.

PMID:
23219670
27.

Cost-effectiveness of switch to matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine bacterial identification.

Gaillot O, Blondiaux N, Loïez C, Wallet F, Lemaître N, Herwegh S, Courcol RJ.

J Clin Microbiol. 2011 Dec;49(12):4412. doi: 10.1128/JCM.05429-11. Epub 2011 Oct 12. No abstract available.

28.

[Detection of extended-spectrum ß-lactamase-producing Enterobacteriaceae in rectal swabs with the Mastdiscs™ ID AmpC ßLSE detection set].

Lemaître N, Loïez C, Pastourel N, Grandbastien B, Loukili N, Dessein R, Courcol R.

Pathol Biol (Paris). 2012 Oct;60(5):e41-4. doi: 10.1016/j.patbio.2011.07.002. Epub 2011 Aug 10. French.

PMID:
21831534
29.

Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens.

Armand S, Vanhuls P, Delcroix G, Courcol R, Lemaître N.

J Clin Microbiol. 2011 May;49(5):1772-6. doi: 10.1128/JCM.02157-10. Epub 2011 Mar 16.

30.

Rodlike fluorescent pi-conjugated 3,3'-bipyridazine ligand: optical, electronic, and complexation properties.

Lincker F, Kreher D, Attias AJ, Do J, Kim E, Hapiot P, Lemaître N, Geffroy B, Ulrich G, Ziessel R.

Inorg Chem. 2010 May 3;49(9):3991-4001. doi: 10.1021/ic901925w.

PMID:
20361752
31.

Isolation of Helcococcus kunzii from plantar phlegmon in a vascular patient.

Lemaître N, Huvent D, Loïez C, Wallet F, Courcol RJ.

J Med Microbiol. 2008 Jul;57(Pt 7):907-8. doi: 10.1099/jmm.0.2008/000471-0.

PMID:
18566154
32.

[A operational plan on behalf of chronic obstructive bronchopneumopathy. 2005-2010. Knowledge, prevention and improved management of COBP].

Biron E, Carré P, Chanez P, Crestani B, Cretin C, Dautzenberg B, Eichler B, Godard P, Grignet JP, Grillet Y, Housset B, Huchon G, Jouniaux V, Lemaitre N, Muir JF, Orvoen Frija E, Pairon JC, Parlange E, Piperno D, Roche N, Roussel JC, Stoebner A, Tillie Leblond I, Trébuchon F, Valdes L.

Rev Mal Respir. 2006 Jun;23 Spec No 3:8S9-8S55. French. No abstract available.

PMID:
17075529
34.

Gentamicin-susceptible or gentamicin-resistant methicillin-resistant Staphylococcus aureus: a case-case study.

Robert J, Bismuth R, Lemaitre N, Jarlier V.

Infect Control Hosp Epidemiol. 2006 Aug;27(8):879-83. Epub 2006 Jul 28.

PMID:
16874652
35.

Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague.

Sebbane F, Lemaître N, Sturdevant DE, Rebeil R, Virtaneva K, Porcella SF, Hinnebusch BJ.

Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11766-71. Epub 2006 Jul 24.

36.

[Question 5. Strategies in respiratory therapy].

Lemoigne F, Desplans J, Lonsdorfer E, Lonsdorfer J, Miffre C, Perruchini JM, Chabry E, Barel P, Bernady A, Ninot G, Lemaitre N, Chouaid C.

Rev Mal Respir. 2005 Nov;22(5 Pt 3):7S100-7S111. Review. French. No abstract available.

PMID:
16340827
37.

Performances of VITEK 2 colorimetric cards for identification of gram-positive and gram-negative bacteria.

Wallet F, Loïez C, Renaux E, Lemaitre N, Courcol RJ.

J Clin Microbiol. 2005 Sep;43(9):4402-6.

38.
39.

Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines.

Guillon J, Grellier P, Labaied M, Sonnet P, Léger JM, Déprez-Poulain R, Forfar-Bares I, Dallemagne P, Lemaître N, Péhourcq F, Rochette J, Sergheraert C, Jarry C.

J Med Chem. 2004 Apr 8;47(8):1997-2009.

PMID:
15055999
40.

Natural radioactive nuclides in some Tunisian thermo-mineral springs.

Labidi S, Dachraoui M, Mahjoubi H, Lemaitre N, Salah RB, Mtimet S.

J Environ Radioact. 2002;62(1):87-96.

PMID:
12141610
41.

Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis.

Lemaitre N, Callebaut I, Frenois F, Jarlier V, Sougakoff W.

Biochem J. 2001 Feb 1;353(Pt 3):453-8.

42.

[Drug resistance in Mycobacterium tuberculosis: diagnostic methods].

Loïez-Durocher C, Vachée A, Lemaitre N.

Ann Biol Clin (Paris). 2000 May-Jun;58(3):291-7. Review. French.

44.

Mycobacterium avium complex common-source or cross-infection in AIDS patients attending the same day-care facility.

Carbonne A, Lemaitre N, Bochet M, Truffot-Pernot C, Katlama C, Grosset J, Bricaire F, Jarlier V.

Infect Control Hosp Epidemiol. 1998 Oct;19(10):784-6.

PMID:
9801289
45.

Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers.

Lemaître N, Sougakoff W, Truffot-Pernot C, Cambau E, Derenne JP, Bricaire F, Grosset J, Jarlier V.

Int J Tuberc Lung Dis. 1998 May;2(5):390-6.

PMID:
9613635
46.

Characterization of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus involved in nosocomial spread.

Lemaître N, Sougakoff W, Masmoudi A, Fievet MH, Bismuth R, Jarlier V.

J Clin Microbiol. 1998 Jan;36(1):81-5.

47.

Nonradioactive single-strand conformation polymorphism analysis for detection of fluoroquinolone resistance in mycobacteria.

Sougakoff W, Lemaître N, Cambau E, Szpytma M, Revel V, Jarlier V.

Eur J Clin Microbiol Infect Dis. 1997 May;16(5):395-8.

PMID:
9228484
48.

Nosocomial transmission of tuberculosis among mentally-handicapped patients in a long-term care facility.

Lemaître N, Sougakoff W, Coëtmeur D, Vaucel J, Jarlier V, Grosset J.

Tuber Lung Dis. 1996 Dec;77(6):531-6.

PMID:
9039446
49.

[Analysis of restriction fragment length polymorphism (RFLP) of Mycobacterium tuberculosis strains isolated from patients with several episodes of tuberculosis].

Lemaitre N, Sougakoff W, Truffot C, Grosset J, Jarlier V.

Pathol Biol (Paris). 1996 May;44(5):452-5. French.

PMID:
8758493

Supplemental Content

Loading ...
Support Center